Conestoga Capital Advisors reported underperformance of its Conestoga Smid Cap Composite in the third quarter of 2025. The letter highlighted West Pharmaceutical Services, Inc. (NYSE:WST) as a strong pick due to its growth potential in specialized packaging and drug delivery systems.